COMP <GO>
ICCM vs NXGL // ENTERPRISE SCALE & MARKET CAP
IceCure Medical Ltd. (NASDAQ) VS. NexGel Inc (NASDAQ) • 15-METRIC TALLY: ICCM 1
— NXGL 5
▲ ENTERPRISE SCALE & MARKET CAP LEADER: ICCM
LAST: $0.87 (-9.05%) • MKT CAP: $3.3M
market-cap
$3.3M
LAST: $3.51 (-9.54%) • MKT CAP: $1.9M
market-cap
$1.9M
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ICCM VS. NXGL)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ICCM | NXGL | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 36.30% | 39.50% | -3.20 | NXGL | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | -29.30% | -30.70 | NXGL | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -26.30% | -33.70 | NXGL | /net-margins <GO> |
| Revenue Growth (YoY) | 2.70% | 31.50% | -28.80 | NXGL | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 0.20 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 5/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 28.5 | 43.0 | -14.50 | NXGL | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $3.3M | $1.9M | $1.4M | ICCM | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ICCM REV | NXGL REV | ICCM GROSS % | NXGL GROSS % | ICCM FCF | NXGL FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.4M | $11.4M | 36.3% | 39.5% | -$14.6M | -$1.4M |
| FY 2024 | $3.3M | $8.7M | 44.1% | 31.6% | -$12.6M | -$4.3M |
| FY 2023 | $3.2M | $4.1M | — | — | -$12.6M | -$3.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ICCM // BETA —
NXGL // BETA —